BioCanRx: Funding Opportunities

​BioCanRx has set the next intake date for funding applications in ​their rolling, open call process. BioCanRx builds on past and ongoing investments in the area of cancer biotherapeutics that have a clear path to, or are ready for, clinical trials. ​The network is strengthening Canada's ability to translate the unfolding promise of immune-based cancer therapies into benefits for patients.

As an open call, this opportunity is open to all investigators located at Canadian institutions eligible to receive peer-reviewed funding from the three federal research-granting councils (CIHR, SSHRC, NSERC).

LOIs are now being accepted for the​ four research programs:

·         Clinical Trials Program
·         Enabling Studies Program
·         Catalyst Program
·         Clinical, Social and Economic Impact Program

If you have questions regarding your eligibility (or that of your institution) or how your project would fit within

​BioCanRx's research program, you are encouraged to contact Dr. Kelley Parato, Director of Scientific Affairs at BioCanRx.
 
Important Dates:
The next intake deadline is November 9, 2016, by 11:59 p.m. EDT.

Contact information: 
For more information, see the Apply for Funding page at the BioCanRx website or contact:
Dr. Kelley Parato
Tel: 613-739-6595

Email: keparato@biocanrx.com

The overall goals of the HeLTI initiative are outlined on the HeLTI webpage. The specific objectives of this funding opportunity are to:

• Through the Cohort Leadership Team:
• Develop a new linked DOHaD intervention-risk cohort composed of a representative sample of the target population in India, including recruitment of women both preconception and during pregnancy, their infants, as well as the fathers;
• Develop and conduct implementation, as well as evaluate implemented interventions for, and with, women and men preconception, during pregnancy and for infants during the postnatal period that are designed to substantially reduce the prevalence of NCDs in children and adolescents;
• Conduct evaluation and mechanistic studies that will explain the effect of the selected interventions on outcomes, including economic analyses of interventions;
• As part of the international HeLTI initiative, develop international multi-country, multi-disciplinary, cross-site collaborations that will provide a learning platform and training environment for new investigators and/or early career stage researchers, support data interoperability and improve harmonization practices
• Generate evidence that will guide policy and other decision-making in the near term through an assessment of retrospective interventions, and identify opportunities for future research and interventions as part of a longer-term strategy for NCD prevention;
• Improve health outcomes, particularly related to women and men’s health preconception, during pregnancy, early life and childhood by targeting early exposures and early development.

he specific objectives of the Start-Up Grant funding opportunity are to:

• Establish new and/or deepen existing partnerships between university-based HSPR doctoral training programs and health system and related employer organizations around shared goals and priorities for the purpose of co-developing pilot experiential learning opportunities for post-doctoral individuals;
• Establish an initial national cohort of fellows (“Health System Impact Fellows”) and leaders from academic and health system organizations with a shared commitment to experiential learning for the purpose of fostering mentorship; professional development; knowledge exchange regarding promising practices for experiential learning; and opportunities for ongoing collaboration;
• Contribute to the creation of an enriched pan-Canadian HSPR curriculum that provides fellows with training in an expanded set of competencies designed to accelerate their professional growth and better prepare them to embark on a wider range of career paths with greater impact.

The specific objectives of this funding opportunity are to:

• Support New Investigators to generate evidence about interventions in health and other sectors that have the potential to promote health and health equity for First Nations, Inuit and Métis Peoples at a population level;
• Catalyze new and existing collaborations involving new investigators, First Nations, Inuit and Métis communities, not-for-profit, private and/or public sectors within and outside of health;
• Facilitate consideration and application of new evidence about population health interventions in decision-making.

The CIHR Roadmap Signature Initiative on Pathways to Health Equity for Aboriginal Peoples is interested in funding population health intervention research projects as a means to support First Nations, Inuit and Métis health research in Canada. Applications must study interventions (e.g. programs, policies, social enterprises and resource distribution approaches) at a national, provincial/territorial and/or regional level and be related to at least one of the Pathways exemplars:

• Suicide prevention
• Obesity/Diabetes
• Tuberculosis
• Oral Health

Eligible applicants are required to include a mentorship plan and to work with a clearly-identified mentor. The mentor will work with the applicant on a plan; review the application before submission; provide advice throughout the project to ensure it is competitive in terms of both scientific excellence and relevance to the topic. Note that a mentor appropriate to the topic of community-based research could be a community or organizational person.

The Foundation Grant program is designed to contribute to a sustainable foundation of health research leaders, by providing long-term support of innovative, high-impact programs of research.

Programs of research are expected to include integrated, thematically-linked research, knowledge translation and mentoring/training components.

The Foundation Grant program will:

• support a broad base of research leaders across career stages, areas, and disciplines relevant to health;
• develop and maintain Canadian capacity in research and other health-related fields;
• provide research leaders with the flexibility to pursue new, innovative lines of inquiry;
• contribute to the creation and use of health-related knowledge through a wide range of research and/or knowledge translation activities, including any relevant collaboration.

The Foundation Grant program includes a separate stream for new/early career investigators with excellent training and early-career success; providing them with an opportunity to build promising programs of research.

The Project Grant program is designed to capture ideas with the greatest potential to advance health-related fundamental or applied knowledge, health research, health care, health systems, and/or health outcomes. It supports projects with a specific purpose and a defined endpoint. The best ideas may stem from new, incremental, innovative, and/or high-risk lines of inquiry or knowledge translation approaches.

The Project Grant program is expected to:

• Support a diverse portfolio of health-related research and knowledge translation projects at any stage, from fundamental discovery to application, including commercialization;
• Contribute to the creation and use of health-related knowledge;
• Promote relevant collaborations across disciplines, professions, and sectors.

The Law Commission of Ontario (LCO) is undertaking a project to review the law of defamation, both generally and as it has been affected by the emergence of the internet. A general description of the project, the LCO’s mandate and associated resources may be found on the LCO’s website at www.lco-cdo.org.

From November 2015 to May 2016, the LCO conducted preliminary research and consultations in order to understand the overall context in which defamation law operates and to identify particular issues that the project will address. Based on this initial work and our ongoing research, the LCO is now developing a consultation paper that will review and analyse a range of issues and set out questions for public consultation. We expect to release the consultation paper in early 2017 and this will form the foundation of the public consultations process that will follow.

The LCO also plans to fund a number of research papers that will inform our development of options for reform. A list of potential research paper topics, application requirements and terms for funding are set out below.

I.    RESEARCH TO BE FUNDED

i.    Objectives

The objective of this Call for Research Papers is to obtain expert input on some longstanding issues of defamation law as well as emerging issues involving the application of defamation law principles to the unique characteristics of internet communications. The resulting research will assist the LCO in developing reasoned, evidence-based and practical reform recommendations. The Call for Research Papers also aims to create critical debate and promote scholarly work on the subject matters at issue.

The LCO takes a holistic approach to law reform and we have adopted a relatively broad approach to this project. We seek to understand defamation law in its modern social and technological context. Is the nature of reputation changing? Is the nature of privacy changing? How does the technology of the internet affect the legal issues? These broader questions will underlie our legal analysis. Therefore, we encourage proposals for multidisciplinary research examining technological, sociological and other perspectives in addition to legal perspectives.

Researchers are encouraged to incorporate relevant quantitative or qualitative research that they have already completed or to undertake original quantitative or qualitative research, so long as it is feasible within the timelines set out below.
 
ii.    Research paper topics

The LCO will fund a number of research papers to be determined after considering all of the proposals we receive. We have identified several potential research paper topics, described below, but also invite proposals that blend elements from one or more of these topics. We will also consider proposals on other topics that would make a demonstrable contribution to our understanding of the issues identified in the project scope statement on our website and that would benefit from external, expert knowledge that the LCO might not be able gain through internal research and consultations.

The Canadian Hemophilia Society (CHS) is proud to put out its call for applications for its research and fellowship programs for the 2017-2018 grant period. The deadline to submit applications for all the programs is November 15, 2016. The eligibility criteria and conditions for all our research programs have been revised and updated. Of note, eligibility has been expanded as follows:

Ø  Dream of a Cure: the program is no longer limited to hemophilia A & B-related projects so that projects focusing on von Willebrand disease, rare factor deficiencies, platelet function disorders (and platelet pathophysiology) and other congenital and acquired bleeding disorders can be supported;

Ø  Dream of a Cure Studentshipsin Inherited Bleeding Disorders Research: similarly to our basic scientific research program, the studentships are no longer limited to hemophilia-related projects but include all inherited bleeding disorders. Furthermore, science students in any year of an undergraduate program can apply in addition to medical students in any year of training;

Ø  CHS/Pfizer Care Until Cure Research Program: the areas of interest to which investigators are encouraged to submit proposals has been expanded to include mild hemophilia B and Factor Utilization & Cost-effectiveness; all projects included but not limited to the list will be considered.

Ø  CHS/Shire Fellowship Program: this is a new program which replaces the program that was sponsored by Baxalta, now with Shire. Unique considerations in the management and care of patients with inhibitors has been added to the list of topics of interest. Applications from hemophilia program professionals/graduate students from the disciplines of nursing, physiotherapy, social work and other related allied health disciplines will be considered. Professional experience in a hemophilia treatment centre is desirable but not required.

Ø  CHS/Novo Nordisk Psychosocial Research Programme: applications from Social Workers, Nurses, or Physiotherapists with professional experience in a hemophilia treatment centre (or other comparable settings in which care has been provided to people with hemophilia and other inherited bleeding disorders) or persons interested in the field of inherited bleeding disorders will be considered. Students in a PhD program in one of the allied health disciplines may also apply. Professionals who have appointments in universities and who can dedicate time to research are encouraged to apply. Professional experience in a hemophilia treatment centre is desirable but not required.

DREAM OF A CURE

Through funds provided by the Hemophilia Research Million Dollar Club and the CHS, the CHS provides basic scientific research grants and studentships aimed at developing treatments for hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders and ultimately, finding a cure.

Dream of a Cure, the CHS Research Program and the 2017 Dream of a Cure Summer Studentships in Inherited Bleeding Disorders Research application forms as well as the general criteria and conditions are available by accessing the CHS Web site at www.hemophilia.ca/en/research/chs-dream-of-a-cure-research-program. For Dream of a Cure, individual grants will be awarded to researchers for one to two years for amounts up to $75,000 per year while support will be offered to interested Canadian medical or science students for up to 4 months for a maximum stipend of $6,000 per student. 

______________________________

CHS / PFIZER CARE UNTIL CURE RESEARCH PROGRAM

You will find at www.hemophilia.ca/en/research/the-chs---pfizer-care-until-cure-research-program  the information for the CHS/Pfizer Care until Cure Research Program offered by the CHS in collaboration with Pfizer Canada. This program allows Canadian investigators to conduct research on medical and psychosocial aspects of bleeding disorders. Grants for one to two years with a maximum of $75,000 per year will be awarded for clinical research, including outcome evaluation, in fields relevant to improving the health and the quality of life for persons with Hemophilia, persons with von Willebrand disease or other inherited bleeding disorders, persons with related conditions such as HIV or hepatitis C infection, and carriers of an inherited bleeding disorder.
______________________________

CHS/Shire Fellowship Program

The CHS/Shire Fellowship Program for Nurses and Allied Health Care Professionals was created to engage hemophilia program professionals/graduate students from the disciplines of nursing, physiotherapy, social work and other related allied health disciplines in research focused on improving services and quality of life for people and families whose lives are affected by bleeding disorders.

This program will offer one or more fellowships not exceeding total funding of $20,000. 

Depending upon the number and quality of applications, funding for different amounts may be possible, as is the offering of more than one fellowship, within the allotted total budget stated above.  

The major portion of each grant would be to cover the research time for the successful candidate(s). A small amount can be devoted to project expenses. Applicants may send their proposals for any one of the following types of fellowships or a combination of these:

• Nursing Fellowship
• Physiotherapy Fellowship
• Social Work Fellowship

Multidisciplinary collaboration

Collaboration with multidisciplinary care providers and/or between two (2) or more hemophilia centres is accepted and encouraged. Collaboration efforts may include, for example, social work, physical therapy and genetics. Inter-regional applications will also be considered.

Applications and deadline

A letter of intent should be submitted to the Canadian Hemophilia Society by November 15, 2016. The letter, with a maximum of two pages, should identify the researcher, the organization and include a summary description of the intended area of research.

The CHS Peer Review Committee will invite a limited number of candidates to submit a more detailed proposal by January 9, 2017 in order to make a final selection. Fellowships will be offered for a one-year period to begin in April 2017.

More detailed information is available by accessing the CHS Web site at http://www.hemophilia.ca/en/research/chs---shire-fellowship-program/   

______________________________

CHS/Novo Nordisk canada Psychosocial Research Programme

The CHS/Novo Nordisk Canada Psychosocial Research Program was created to engage hemophilia program professionals/graduate students from the allied health disciplines (ie. Nursing, Physiotherapy & Social Work) in research activities addressed to understanding the psychosocial impact of hemophilia and other inherited bleeding disorders and to improve the quality of life of persons and families whose lives are affected by these disorders.

The primary intent of this program is to offer one or two $20,000 research grants, to a maximum of $40,000 for one year.

Depending upon the number and quality of applications, funding for more than two research grant could be offered within the allotted total budget stated above.

The major portion of each grant would be to cover the research time for the successful candidate(s), including the time for research assistants. A small amount can be devoted to project expenses.

Multidisciplinary Collaboration:
Collaboration with multidisciplinary care providers and/or between two or more hemophilia centres is accepted and encouraged. Collaboration efforts may include, for example, social work, physical therapy and genetics. It thus may be possible for a hemophilia centre team to jointly submit a cooperative research project. Additionally, inter-regional applications will be considered.
 
Applications and Deadline:
A letter of intent should be submitted to the Canadian Hemophilia Society by November 15, 2016. The letter, with a maximum of two pages, should identify the researcher, the organization and include a summary description of the intended area of research.

The CHS Peer Review Committee will invite a limited number of candidates to submit a more detailed proposal by January 9, 2017 in order to make a final selection. Grants will be offered for a one-year period to begin in April 2017.

More detailed information is available by accessing the CHS Web site at www.hemophilia.ca/en/research/chs---novo-nordisk-psychosocial-research-program

______________________________

Please feel free to distribute this information to others who may be interested in applying. The research must be conducted in Canada by researchers affiliated with Canadian universities and not-for-profit-related organizations.

If you require further information, please do not hesitate to contact Mr. Michel Long at the CHS National Office at 1-800-668-2686 or by e-mail at mlong@hemophilia.ca.

Sincerely,

Michel Long
National Program Manager | Gestionnaire national des programmes
Canadian Hemophilia Society | Société canadienne de l'hémophilie

301-666, rue Sherbrooke Ouest, Montréal (QC) H3A 1E7
     514 848-0503, # 225 | 1 800 668-2686

     514 848-9661

    mlong@hemophilia.ca 
www.hemophilia.ca

The Preterm Birth Initiative was created to increase the understanding of the biological mechanisms underlying parturition and spontaneous preterm birth and will provide up to $600,000 over a four-year period ($150,000 per year).

The initiative is designed to stimulate both creative individual scientists and multi-investigator teams to approach the problem of preterm birth using creative basic and translation science methods. Postdoctoral fellows nearing their transition to independent investigator status through senior established investigators are encouraged to apply.

Molecular and computational approaches such genetics/genomics, immunology, microbiology, evolutionary biology, mathematics, engineering, and other basic sciences hold enormous potential for new insights independently or in conjunction with more traditional areas of parturition research such as maternal fetal medicine, obstetrics, and pediatrics